Currently, the clinically applied derivatives of artemisinin include:

• water-soluble Artesunate
• lipophilic Artemether
• Arteether
• Dihydroartemisinin \ Dihydroqinghaosu.

These derivatives have antiviral, anti-inflammatory, and antitumor effects. For patients experiencing symptoms after receiving 2 to 3 vaccine doses, the only solution is artesunate, which can expel spike proteins and graphene oxide from the vaccines and viruses, achieving a cure rate of up to 90%. Due to its safety and high bioavailability, artesunate binds to iron in cancer cells, releasing free radicals that kill cancer cells while also inhibiting tumor blood vessel growth.